Inhibikase Halts Parkinson's Drug Development to Focus on PAH
Inhibikase Therapeutics, Inc. (IKT), a biopharmaceutical company with a market capitalization of $189.48 million, has announced the halting of further development of its Parkinson's disease drug, ...
Inhibikase Therapeutics stops Parkinson's drug development as it fails to show benefits in study
Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...
Northern Virginia Daily13h
Exercise class helps Parkinson's patients manage their symptoms
Patients living with Parkinson’s disease are encouraged to engage in regular exercise to help manage symptoms and improve ...
AZoLifeSciences on MSN14h
Researchers Apply Advanced AI Genetics Models to Study Parkinson's Disease
Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...
AI model identifies potential risk genes for Parkinson's disease
Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...
Can mold exposure cause Parkinson's disease? Colorado family hopes to prove 'landmark' legal case
A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month ...